Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | QDPR | P09417 | 2/20 | 0.40 |
| ▸ | PDE4A | P27815 | 8/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10029360 | 0.86 | QDPR (0.50) | QDPRPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL11035526 | 0.84 | CYP2C9 (0.49) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL11035523 | 0.84 | CYP2C9 (0.49) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL11035520 | 0.84 | CYP2C9 (0.49) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL20634845 | 0.80 | CYP2C9 (0.45) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL16186374 | 0.79 | CYP2C9 (0.49) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL14492330 | 0.78 | PDE4A (0.49) | CYP2C9ALDH1A1MAPTLMNAMAPK1 | |
| SCHEMBL9399894 | 0.77 | SSTR4 (0.45) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL29186350 | 0.77 | CYP2C9 (0.50) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL9399311 | 0.77 | CYP2C9 (0.50) | CYP2C9ALDH1A1MAPTLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2275413-B1 | 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders | NOVARTIS AG (CH) | 2013-03-06 | — | — | EP | disclosed |